Skip to content

Industry Event

Partnerships in Clinical Trials US

Delegates from all parts of the clinical trial value chain come to Partnerships in Clinical Trials to quickly identify, engage and enter into strategic relationships that drive their clinical trials successfully forward as well as take part in the 60+ sessions and workshops geared to focus on several topic areas of interest, including risk-based monitoring, strategic sourcing, emerging market, patient adherence and more. This year’s Partnerships in Clinical Trials event is expected to draw upwards of 1,300 industry attendees for four days of high level networking, idea exchange and innovation.

Wednesday, April 22, 2015 @ 9:15am

The A-to-Z of RBM: Learn the key elements of risk management including terminology, definitions, principles and application in the clinical study area

Andy Lawton, Global Head of Data Management, Biometrics & Data Management, Boehringer Ingelheim


Wednesday, April 22, 2015 @ 2:00pm

Expert Panel: Collaborative Methodology for Risk-Based Monitoring of Clinical Trials: Practical Experience and Updates from TransCelerate Companies

Andy Lawton, Global Head of Data Management, Biometrics & Data Management, Boehringer Ingelheim

Mike Luker, Director, Clinical Research, Eli Lilly & Co.

Rebhar Tayyabkhan, Executive Director, Bristol-Myers Squibb


Thursday, April 23, 2015 @ 9:15am

Redefining Clinical Trials in the Age of Personalized Medicine

Ülo Palm, MD, PhD, MBA, SVP, Drug Development & Research Operations, Forest Laboratories

Isan Chen, MD, EVP, Chief Medical and Development Officer, Mirati Therapeutics

Erynn Gordon, Medical Marketing Director, 23&Me

Wendy Levin, MD, MS, Vice President, Clinical Development & Medical Affairs, MEI Pharma, Inc.

Niven Narain, Co-Founder, President & Chief Technology OfficerBerg Health


Thursday, April 23, 2015 @ 10:00am

Starting with a Blank Slate: how Would You Shape an Ideal Partnership

Andy Lee, Senior Vice President, Global Clinical Trial Operations, Merck

Murray Abramson, VP, Clinical Operations, Biogen Idec

Kenneth Getz, Director of Sponsored Programs, Tufts University School of Medicine

Paula Gildert, Head Development Strategic Sourcing DSS, Novartis Pharma AG

Harris Koffer, President of Strategic Solutions, PRA Health Sciences

John Oidtman, VP, Pfizer

Bernard Ravina, VP, Clinical Development, Voyager Therapeutics
Thursday, April 23, 2015 @ 11:15am

Show Me Your Data: How Transparency is Driving Drug Development

Andy Lawton, Global Head of Data Management, Biometrics & Data Management, Boehringer Ingelheim

Lynn Marks, MD, SVP Projects, Clinical Platforms & Science, GlaxoSmithKline

Peter Pitts, Former FDA Associate Commissioner for External Relations, President, Center for Medicine in the Public Interest


Friday, April 24. 2015 @ 9:45am

Update on TransCelerate Initiatives for 2015 + Beyond

Dalvir Gill, PhD – Chief Executive Officer at TransCelerate BioPharma Inc.

Andy Lee, SVP, Head of Global Clinical Trial Operations at Merck & Co

Reb Tayyabkhan, Head of Central Clinical Services at Bristol-Myers Squibb)

Craig Lipset – Head of Clinical Innovation at Pfizer